Watchlist Price Alert

IRadimed Corporation (IRMD)

NASDAQ: IRMD · Real-Time Price · USD

58.41

0.24 (0.41%)

At close: Jun 16, 2025, 3:59 PM

58.52

0.18%

After-hours: Jun 16, 2025, 04:04 PM EDT

0.41% (1D)

Bid	55.6
Market Cap	742.75M
Revenue (ttm)	75.15M
Net Income (ttm)	19.78M
EPS (ttm)	1.55
PE Ratio (ttm)	37.69
Forward PE	29.96
Analyst	Strong Buy

Ask	60
Volume	35,618
Avg. Volume (20D)	36,942
Open	58.08
Previous Close	58.17
Day's Range	57.78 - 58.80
52-Week Range	42.11 - 63.29
Beta	0.93

About IRMD

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol IRMD

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for IRMD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

4 months ago

-8.38%

Iradimed shares are trading lower. The company rep... Unlock content with Pro Subscription

News

4 days ago · zacks.com

New Strong Sell Stocks for June 12th

LYB, IRMD and SONY have been added to the Zacks Rank #5 (Strong Sell) List on June 12, 2025.

1 month ago · seekingalpha.com

IRADIMED CORPORATION (IRMD) Q1 2025 Earnings Call Transcript

IRADIMED CORPORATION (NASDAQ:IRMD ) Q1 2025 Earnings Conference Call May 5, 2025 9:00 AM ET Company Participants Roger Susi - Founder, President & CEO John Glenn - CFO Conference Call Participants Fra...

1 month ago · zacks.com

IRadimed (IRMD) Lags Q1 Earnings Estimates

IRadimed (IRMD) came out with quarterly earnings of $0.42 per share, missing the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.36 per share a year ago.

2 months ago · seekingalpha.com

IRadimed Corporation: Steady, Low-Risk Grower In The Devices Space

IRadimed Corporation offers steady revenue growth with 14 consecutive quarters of record revenue and a small dividend, despite recent stock price decline. IRMD's unique MRI-compatible IV infusion pump...